Clinical Trial Update: Survey on the Pharmacy Follow-up of Alli Purchasers

View source ↗

Summary

A completed clinical trial update reporting the results of a survey on how pharmacies follow up with Alli (orlistat) purchasers for overweight individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overweight

Drugs mentioned

• ALLI (orlistat)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Overweight | Status: COMPLETED